| abstract |
The present invention relates to compounds of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereofn n n <Formula I>n n n n n n n n (Wherein the variables R, R9, Z, X, Q and Y are as defined herein.)n n n Chemokine receptor antagonists, compounds, pharmaceutically acceptable salts, esters, prodrugs, autoimmune or inflammatory diseases or conditions, HIV infection or AIDS |